Noile-Immune Biotech Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Noile-Immune Biotech Inc. made a loss over the last year. Noile-Immune Biotech Inc. owes ¥0.02 for every ¥1 it owns. Noile-Immune Biotech Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
LossNoile-Immune Biotech Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.07The share price is 1.07 times Noile-Immune Biotech Inc.'s book value per share, lower than 73% of Healthcare companies in Japan.
Market cap
¥3.8 BThe total market value of all of Noile-Immune Biotech Inc.'s shares at today's price (share price × number of shares), smaller than 84% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥3.6 BWhat Noile-Immune Biotech Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥82.36Net worth divided by the number of shares. The share price of ¥88.00 is 1.1 times this, which is the P/B above.
Return on equity (ROE)
-19.1%Noile-Immune Biotech Inc. lost 19.1% of its shareholders' money over the last year, lower than 80% of Healthcare companies in Japan.
Owes vs Owns
0.02×Noile-Immune Biotech Inc. owes ¥0.02 for every ¥1 it owns (low), lower than almost all Healthcare companies in Japan.
Dividend yield
NoneNoile-Immune Biotech Inc. does not currently pay a dividend.
Revenue growth
-34%Revenue fell 34% in the year to Dec 2025, and shrank 80% a year on average over 3 years.
Profit growth
LossNoile-Immune Biotech Inc. made a loss in each of the last two years.
Profit margin
-15870.7%Noile-Immune Biotech Inc. lost ¥15871 for every ¥100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Noile-Immune Biotech Inc.: ¥3.8 B ÷ ¥3.6 B (30 Jun 2026) = 1.1.
What is Noile-Immune Biotech Inc.'s return on equity?
Noile-Immune Biotech Inc. lost 19.1% of its shareholders' money over the last year, lower than 80% of Healthcare companies in Japan.
How much does Noile-Immune Biotech Inc. owe compared with what it owns?
Noile-Immune Biotech Inc. owes ¥0.02 for every ¥1 it owns (low), lower than almost all Healthcare companies in Japan.
Does Noile-Immune Biotech Inc. pay a dividend?
No. Noile-Immune Biotech Inc. does not currently pay a dividend.
Is Noile-Immune Biotech Inc.'s revenue growing?
Revenue fell 34% in the year to Dec 2025, and shrank 80% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.